Gilead

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines for people with life-threatening diseases. The company focuses on three therapeutic areas — virology (HIV and hepatitis), oncology, and inflammation — where unmet medical needs remain greatest, and its medicines are sold in more than 35 countries. Gilead employs more than 17,000 people globally and is known for breakthrough antiviral therapies including Sovaldi, Harvoni, and Biktarvy, as well as oncology drugs developed through its acquisitions of Kite Pharma and Immunomedics. Beyond medicine, the company invests in access programs and partnerships to expand reach to patients in low- and middle-income countries.